Search research articles
Contact Us
Filters
Showing results (821-830 of 831) with videos related to
Page
of 84
Sort By:
Cell Death & Disease
|
June 12, 2023
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid
Xian-Yang Qin, Yutaka Furutani, Kento Yonezawa, et al.
Neuro-Oncology Advances
|
July 10, 2020
MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment
Yu-Ting Su, Madison Butler, Meili Zhang, et al.
Frontiers in Plant Science
|
December 31, 2025
Evaluation of biocontrol agents for the management of sorghum anthracnose caused by <i>Colletotrichum sublineola</i>
Ji-Wei Zhang, Jun-Ru Han, Fei-Fei Zhao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 16, 2022
Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis
Hui-Teng Cheng, Hsi-Chien Huang, Tsung-Ying Lee, et al.
Frontiers in Oncology
|
February 1, 2021
Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy
Guangyang Yu, Madison K Butler, Abdalla Abdelmaksoud, et al.
BMC Medical Education
|
June 29, 2024
Developing an entrustable professional activity for providing health education and consultation in occupational therapy and examining its validity
Chung-Pei Fu, Ching-Kai Huang, Yi-Chiun Yang, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 20, 2009
Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor
Penglie Zhang, Wenrong Huang, Lingyan Wang, et al.
Human Mutation
|
July 26, 2012
Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa
Bert Callewaert, Chi-Ting Su, Tim Van Damme, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 8, 2025
Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study
Sarah M Baxter, Lars Christian Lund, Jacob H Andersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2021
Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
Jing Wu, Ying Yuan, Debra A Long Priel, et al.
Page
of 84
Search research articles
Search
Showing results (821-830 of 831) with videos related to
Sort By:
Page
of 84
Cell Death & Disease
|
June 12, 2023
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid
Xian-Yang Qin, Yutaka Furutani, Kento Yonezawa, et al.
Neuro-Oncology Advances
|
July 10, 2020
MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment
Yu-Ting Su, Madison Butler, Meili Zhang, et al.
Frontiers in Plant Science
|
December 31, 2025
Evaluation of biocontrol agents for the management of sorghum anthracnose caused by <i>Colletotrichum sublineola</i>
Ji-Wei Zhang, Jun-Ru Han, Fei-Fei Zhao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 16, 2022
Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis
Hui-Teng Cheng, Hsi-Chien Huang, Tsung-Ying Lee, et al.
Frontiers in Oncology
|
February 1, 2021
Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy
Guangyang Yu, Madison K Butler, Abdalla Abdelmaksoud, et al.
BMC Medical Education
|
June 29, 2024
Developing an entrustable professional activity for providing health education and consultation in occupational therapy and examining its validity
Chung-Pei Fu, Ching-Kai Huang, Yi-Chiun Yang, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 20, 2009
Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor
Penglie Zhang, Wenrong Huang, Lingyan Wang, et al.
Human Mutation
|
July 26, 2012
Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa
Bert Callewaert, Chi-Ting Su, Tim Van Damme, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 8, 2025
Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study
Sarah M Baxter, Lars Christian Lund, Jacob H Andersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2021
Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
Jing Wu, Ying Yuan, Debra A Long Priel, et al.
Page
of 84